Update on pediatric heart transplantation. Long-term complications.

AUTOR(ES)

Gajarski, R J

RESUMO

Despite evolution to "higher-order" immunosuppressive agents that better control cell-mediated allograft rejection and, therefore, short- and intermediate-term survival, allograft vasculopathy and PTLD remain factors that limit extended graft survival. While improved basic science "bench" techniques have enabled investigation of their pathogenesis at the subcellular and molecular levels, each scientific advance leads the way to the next horizon of complex questions. Only through a more complete understanding of the etiology and pathophysiology of these processes will we be able to design strategies to combat these complications.

Documentos Relacionados

• Long-term complications of cardiac transplantation.
• Long-term results of pediatric liver transplantation: an analysis of 569 transplants.
• Long-term results of pediatric liver transplantation in a combined pediatric and adult transplant program
• Long-term complications of laparotomy in Hodgkin's disease.
• Experimental supratrigonal cystectomy: evaluation of long-term complications